Literature DB >> 11154921

The mannan-binding-lectin pathway of the innate immune response.

M Gadjeva1, S Thiel, J C Jensenius.   

Abstract

Dramatic progress has been achieved during the past year in our understanding of how the complement system is activated via the mannan-binding-lectin pathway. Surprising discoveries have changed our concepts of the complexes that are formed upon engagement of mannan-binding lectin with its serine proteases.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11154921     DOI： 10.1016/s0952-7915(00)00185-0

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN： 0952-7915            Impact factor:   7.486


  21 in total

Review 1.  Modern complement analysis.

Authors:  Michael Kirschfink; Tom E Mollnes
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

2.  The ancient origin of the complement system.

Authors:  Yong Zhu; Saravanan Thangamani; Bow Ho; Jeak Ling Ding
Journal:  EMBO J       Date:  2004-12-23       Impact factor: 11.598

3.  Identification of the insulin-like growth factor II receptor as a novel receptor for binding and invasion by Listeria monocytogenes.

Authors:  Uta Gasanov; Craig Koina; Kenneth W Beagley; R John Aitken; Philip M Hansbro
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

4.  Mannose binding lectin levels are not related to radiographic damage in ankylosing spondylitis.

Authors:  Sibel Zehra Aydin; Pamir Atagunduz; Burak Erer; Cengiz Bahadir; Nevsun Inanc; Haner Direskeneli
Journal:  Rheumatol Int       Date:  2010-01       Impact factor: 2.631

5.  Complement C4 monitoring in the follow-up of chronic hepatitis C treatment.

Authors:  C Dumestre-Perard; D Ponard; C Drouet; V Leroy; J-P Zarski; N Dutertre; M G Colomb
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

6.  Mannose binding lectin acute phase activity in patients with severe infection.

Authors:  M M Dean; R M Minchinton; S Heatley; D P Eisen
Journal:  J Clin Immunol       Date:  2005-07       Impact factor: 8.317

7.  Phase I safety, tolerability, and pharmacokinetic study of recombinant human mannan-binding lectin.

Authors:  Kenneth Ahrend Petersen; Finn Matthiesen; Teit Agger; Leif Kongerslev; Steffen Thiel; Karen Cornelissen; Mads Axelsen
Journal:  J Clin Immunol       Date:  2006-08-09       Impact factor: 8.317

8.  Analysis of Rickettsia typhi-infected and uninfected cat flea (Ctenocephalides felis) midgut cDNA libraries: deciphering molecular pathways involved in host response to R. typhi infection.

Authors:  S M Dreher-Lesnick; S M Ceraul; S C Lesnick; J J Gillespie; J M Anderson; R C Jochim; J G Valenzuela; A F Azad
Journal:  Insect Mol Biol       Date:  2009-12-15       Impact factor: 3.585

9.  Effects of complement regulators bound to Escherichia coli K1 and Group B Streptococcus on the interaction with host cells.

Authors:  Ravi Maruvada; Anna M Blom; Nemani V Prasadarao
Journal:  Immunology       Date:  2007-11-20       Impact factor: 7.397

10.  Genetic Susceptibility to Sepsis: A Possible Role for Mannose-binding Lectin.

Authors:  Peter Garred; Hans O Madsen
Journal:  Curr Infect Dis Rep       Date:  2004-10       Impact factor: 3.725
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.